KONINKLIJKE PHILIPS NV (PHG) Stock
PHG has an Alpha Score of 58 out of 100 (moderate), computed on Oct 30, 2026 from 3 of 4 sub-scores. 5 members of Congress disclosed 14 trades in PHG since 2015: 9 purchases and 5 sales, most recently Earl Blumenauer (purchase, Feb 12, 2024). 3 of the hedge funds AlphaScala tracks reported PHG in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Citadel's at $4.21M. Its trailing P/E ratio is 22.4 and its net margin 6.3% (key statistics as of Nov 5, 2026).
What is PHG's Alpha Score?
How it works →Alpha Score of 58 reflects moderate overall profile with strong momentum, moderate value, moderate quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Oct 30, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded KONINKLIJKE PHILIPS NV (PHG)?
Most recent: Earl Blumenauer (purchase, Feb 12, 2024); records start Jan 27, 2015.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Earl Blumenauer D-OR · House | 2024-02-12 | purchase | $1k – $15k |
| Dan Goldman D-NY · House | 2023-07-10 | sale | $1k – $15k |
| Earl Blumenauer D-OR · House | 2022-07-27 | purchase | $1k – $15k |
| Katherine Clark D-MA · House | 2021-09-16 | sale | $1k – $15k |
| Katherine Clark D-MA · House | 2020-11-05 | purchase | $1k – $15k |
| Dean Phillips D-MN · House | 2020-04-22 | purchase | $1k – $15k |
| Dean Phillips D-MN · House | 2020-03-05 | purchase | $1k – $15k |
| Dean Phillips D-MN · House | 2020-02-21 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 5, 2026.
See all PHG political trades →Which hedge funds own PHG?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Citadel Ken Griffin | 155K | $4.21M | -35% |
| Point72 Steve Cohen | 87K | $2.37M | -46% |
| Millennium Management Israel Englander | 17K | $454.4K | -97% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →What are PHG's key statistics?
Key statistics as of Nov 5, 2026
How does PHG's valuation compare with the Healthcare sector?
| Metric | PHG | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 22.4 | 28.7 | 108 |
| Net margin | 6.30% | 4.11% | 160 |
| Return on equity | 10.04% | 5.18% | 180 |
| Dividend yield (payers) | 4.15% | 1.59% | 55 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 6, 2026). P/E excludes loss-making companies.
PHG price chart
Powered by TradingViewWhat does KONINKLIJKE PHILIPS NV do?
Koninklijke Philips N.V. is a prominent multinational corporation with a core focus on health technology. Having evolved from its roots in lighting and consumer electronics, the company now spearheads innovations in diagnostic imaging, image-guided therapy, and consumer health products. Philips is instrumental in the healthcare sector, providing integrated solutions that enhance patient care and operational efficiency in medical facilities worldwide. A significant player in the health systems domain, Philips offers a portfolio that includes ultrasound devices, MRIs, and CT scanners, alongside patient monitoring systems and advanced health informatics. By integrating smart technologies into healthcare, Philips supports digital transformation initiatives within medical institutions, thus playing a crucial role in the transition towards more connected and predictive healthcare systems. As a market leader in personal health, Philips delivers a range of products from oral healthcare to maternal and child care. Headquartered in Amsterdam, the Netherlands, Koninklijke Philips N.V. is committed to innovation and sustainability, driving advancements that aim to improve the lives of billions globally while reducing environmental impact.